Science Explorer Interactive view Map
Company · Los Angeles · United States

Kirin (United States)

kirinusa.beerROR OpenAlex
Research works
59
▲ 114% vs 2013–17
Citations
1.1k
18.9 per fractional work
Top-10% rate
12.5%
record average 16.5%
Open access
44%
world 28%

Not ranked overall: Kirin (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.53× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.91× its world share, 0 worksImmunology and Micro…Neuroscience: 0.16× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.53× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.43× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.11× its world share, 0 worksEngineeringMathematics: 0.25× its world share, 0 worksMathematicsMedicine: 3.78× its world share, 9 worksMedicineNursing: 3.23× its world share, 0 worksNursingVeterinary: 1.64× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 1.24× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.9×. Every wedge is a field page.

Which keywords describe research at Kirin (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Lymphoma, Cutaneous Lymphomas, Mycosis Fungoides, Rituximab, Immunotherapy, Leukemia and Cancer Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors7▲ 25×5 topics
  2. Lymphoma7▲ 76×3 topics
  3. Cutaneous Lymphomas5▲ 467×1 topic
  4. Epidemiology5▲ 2.1×22 topics
  5. Mycosis Fungoides5▲ 467×1 topic
  6. Rituximab4▲ 45×3 topics
  7. Immunotherapy4▲ 11×7 topics
  8. Leukemia4▲ 100×2 topics
  9. Inflammation4▲ 2.6×15 topics
  10. Cancer Immunotherapy3▲ 39×2 topics
  11. Gene Expression Profiling3▲ 53×2 topics
  12. Molecular Profiling3▲ 44×2 topics
  13. PET Imaging3▲ 23×2 topics
  14. Classification3▲ 13×1 topic
  15. Genetic Pathogenesis3▲ 80×1 topic
  16. Oxidative Stress3▲ 2.5×7 topics
  17. CAR T Cells3▲ 104×1 topic
  18. Chimeric Antigen Receptor3▲ 104×1 topic
  19. Tumor Regression3▲ 53×2 topics
  20. Therapeutic Targets3▲ 19×3 topics
  21. Neurodegeneration2▲ 13×4 topics
  22. Parkinson's Disease2▲ 18×4 topics
  23. Dopaminergic Neurons2▲ 56×2 topics
  24. Tumor Microenvironment2▲ 10×6 topics
  25. Genetic Risk Factors2▲ 67×1 topic
  26. a-Synuclein2▲ 67×1 topic
  27. Viral Transmission2▲ 33×3 topics
  28. Heat Transfer2▲ 5.5×5 topics
  29. Neuroprotection2▲ 7.3×2 topics
  30. Infection1▲ 8.3×3 topics
  31. Adenosine Receptors1▲ 88×1 topic
  32. Purinergic Signalling1▲ 88×1 topic
  33. Chronic Lymphocytic Leukemia1▲ 43×1 topic
  34. Fermentation1▲ 13×2 topics
  35. Genomic Aberrations1▲ 43×1 topic
  36. HTLV-11▲ 91×1 topic
  37. Vaccine1▲ 5.2×7 topics
  38. proviral load1▲ 91×1 topic
  39. Chronic Kidney Disease1▲ 7.6×2 topics
  40. Turbulent Flows1▲ 14×2 topics

Which research topics does Kirin (United States) publish most on?

By volume in 2022–2025: Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research and Parathyroid Disorders and Treatments.

Cutaneous lymphoprolifer…2Cutaneous lymphoproliferative disorders research: 2 fractional worksLymphoma Diagnosis and Treatment: 1 fractional worksCAR-T cell therapy research: 1 fractional worksParathyroid Disorders and Treatments: 1 fractional worksAdenosine and Purinergic…0Adenosine and Purinergic Signaling: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksParkinson's Disease Mechanisms and Treatments: 0 fractional worksNail Diseases and Treatments: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksPharmacological Receptor Mechanisms and Effects: 0 fractional works
DermatologyPathology and Forensic MedicineOncologyNephrology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cutaneous lymphoproliferative disorders research Dermatology 2 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  3. 3 CAR-T cell therapy research Oncology 1 works
  4. 4 Parathyroid Disorders and Treatments Nephrology 1 works
  5. 5 Adenosine and Purinergic Signaling Physiology 0 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 0 works
  7. 7 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  8. 8 Nail Diseases and Treatments Epidemiology 0 works
  9. 9 Dermatology and Skin Diseases Dermatology 0 works
  10. 10 Pharmacological Receptor Mechanisms and Effects Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.8%not open56.2%

World: 28% of research is openly available.

with international co-authors49.2%domestic only50.8%

World: 19% is written across borders.

How has Kirin (United States)'s research output changed?

Output in 2018–2022 was 114% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Los Angeles

All research institutions in Los Angeles

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.